Pre-Congress Workshops - 21st April @ 10:00
BIODEFENSE
Protecting public health from biothreats to pandemics.
- What is the progress on new technologies in medical product development?
- How our governments are incentivizing (portfolio approach), especially with biotech and industry? What International collaborations are being facilitated?
How our governments are incentivizing (portfolio approach), especially with biotech and industry?
10:10 Melinda Hamer, Operating Partner, GHIC
10:30 BARDA & Sabin: Kelly Warfield, Sabin Vaccine Institute’s President of Research & Development, Sabin Institute
10:50 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security
Col Matt Clark, Joint Project Manager, CBRN, JPEO-CBRND
Kevin Webb, COO, API Innovation Center
Chan Harjivan, Former Assistant at The White House & Chief Strategy Officer, The Medical Countermeasures Coalition
11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation
Moderator: Praneel Jadav, Manager, Infectious Disease Policy, BIO
Mike Stebbins, Manufacturing and Threat Countermeasures Division, ATI
Renee Hart, President & CBO, LumaCyte
Lakshmi Krishnan, Vice President of Research, National Research Council of Canada
1:00 - 2:00 break
2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?
Moderator: Dr Philip Krause, Independent Consultant & Former FDA
William Falstich, VP, Primary Care Category Supply Chain Lead, Pfizer
Dr Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UKHSA
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Marion Gruber, Vice President, Public Health and Regulatory Affairs, IAVI
Kent Kester, Executive Director, Vaccine Research and Development, CEPI
3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?
Moderator: Soazic Elise Wang Sonn, Economist, World Bank Group, Washington D.C.
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Dr Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, African Center of Excellence for Genomics of Infectious Diseases (ACEGID)
Megan Rauscher, Senior Manager, Private Sector Program Lead, ThinkWell
Dr Monique K Mansoura, Executive Director, Global Health Security & Biotechnology, Independent
Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director,
ACEGID
Christian Happi, is a Professor of Molecular Biology and Genomics and Director of the World Bank funded African Center of Excellence for Genomics of infectious Diseases, (ACEGID), Redeemer’s University, Ede, Nigeria.
He did his postdoctoral fellowship at Harvard University (2000-2003), and...
Kelly Warfield, President, R&D,
Sabin Vaccine Institute
Kelly Warfield, PhD, joined the Sabin Vaccine Institute as its President of Research & Development in August 2024.
In this role, Kelly collaborates with executive team members, cross-functional leaders, and the Board of Trustees to drive Sabin’s strategic vision, manage and grow the R&D...
Matthew G. Clark, Joint Project Manager, CBRN Medical,
JPEO-CBRND
Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading themedical portfolio for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).
...
Chandresh Harjivan, Chief Strategy Officer,
The Medical Countermeasures Coalition
PwC and BCG Managing Director and Partner; leading the Public Health practicesOperation Warp Speed Senior leader and architect, from inception to vaccine roll outCo-Founder of successful start-up at SaponiQx (vaccine adjuvant); $0 to $250M valuation on exitSpecial Assistant to the President for...
Praneel Jadav, Manager, Infectious Disease Policy,
BIO
Praneel Jadav is the Manager of Infectious Disease Policy at the Biotechnology Innovation Organization. In this capacity, Praneel leads BIO's Biodefense and Pandemic Preparedness portfolio as well as supporting BIO's core strategic priority of "Biotechnology as a Core National Security ...
Renee Hart, President & CBO,
LumaCyte
Renee Hart serves as the President and Chief Business Officer of LumaCyte, bringing over 25 years of executive experience in life sciences operations and business leadership. Her broad and deep experience and diverse expertise across clinical development, commercialization strategies, bioanalytical ...
Lakshmi Krishnan, Vice-President, Life Sciences,
National Research Council Canada
Dr. Lakshmi Krishnan is the Vice-President of Life Sciences at the National Research Council, Canada (NRC). In this capacity, she oversees the Human Health Therapeutics, Aquatic and Crop Resource Development and Medical Devices research centers.
As a globally recognized Life Sciences...
Seth Berkley, Senior Advisor,,
Pandemic Center at Brown Univertsity
A medical doctor and infectious disease epidemiologist, Dr Seth Berkley is currently serving as an advisor and Board member to numerous health and technology companies and is an Adjunct Professor at the Pandemic Center at Brown University. He previously was CEO of Gavi, the Vaccine Alliance from...
SOAZIC ELISE WANG SONNE, Economist,
World Bank Group
Soazic Elise Wang Sonne is an Economist and data scientist with the Health, Nutrition and Population (HNP) unit of the World Bank Group based in Washington, DC. She has been leading immunization financing analytical work in Lower Middle-Income Country (LMIC) countries in the Africa...
Santiago Cornejo, Executive Manager, Regional Revolving Funds,
PAHO
Mr. Cornejo has a master’s degree in international development studies from George Washington University. He started his career in academia and many international organizations. He joined the Gavi Alliance in 2008 where he held different responsibilities, including the development and management of ...
William Falstich, Vice President, Global Supply Chain, Primary Care,
Pfizer
Bill Falstich is Vice President of Pfizer’s Primary Care Category Global Supply Chain. His team of 50 colleagues manages supply for some of the world’s largest vaccines, a broad Internal Medicines portfolio, and Pfizer’s Paxlovid antiviral. His team also plays a critical role in the...
Kevin Webb, COO,
API Innovation Center
Kevin Webb is the Chief Operating Officer of the API Innovation Center where he has direct responsibility for business operations, programs, strategy and external engagement. He leads the API Innovation Center’s efforts at a national and regional level to strengthen domestic pharmaceutical...
Monique K. Mansoura, Executive Director, Global Health Security & Biotechnology,
Independent
From 2002-2011, she led strategic policy, planning and budgeting for a pioneering multibillion-dollar medical countermeasures development and acquisition program in the U.S. Department of Health and Human Services under the authorities of the Project BioShield Act of 2004 and the Pandemic and...
